Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Graft-versus-host disease (GVHD) is a serious complication that can occur after bone marrow or stem cell transplantation, where the transplanted donor immune cells attack the recipient's healthy tissues. While GVHD is primarily diagnosed through clinical symptoms and tissue examination, blood testing plays a crucial role in monitoring immune system function and managing complications.
This comprehensive test evaluates immune cell activity and function, which is critical for monitoring GVHD progression. Since GVHD occurs when transplanted immune cells abnormally attack the recipient's body tissues, assessing immune cell function helps healthcare providers understand the severity of the immune dysfunction and adjust treatment accordingly.
GVHD involves complex immune system dysfunction that affects the body's ability to maintain proper immune balance. Blood tests are fundamental for assessing immune cell activity, monitoring treatment response, and detecting complications early. These tests help healthcare providers adjust immunosuppressive medications and guide overall management strategies.
In GVHD, the delicate balance of immune system regulation is disrupted. Monitoring immune cell function through blood testing provides valuable insights into how well immunosuppressive treatments are working and whether additional interventions may be needed to protect healthy tissues while maintaining the beneficial effects of the transplant.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.